# Glipizide and Metformin Hydrochloride

NDC: 0093-7455
Generic name: Glipizide and Metformin Hydrochloride
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20051028

FDA application: ANDA077270

## Active ingredients

- GLIPIZIDE: 2.5 mg/1
- METFORMIN HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-7455"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-7455
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03d9ce02-0559-494c-a53d-de9b9a64b606